RNS Number : 6593A
Aquis Exchange PLC
23 January 2024

23 January 2024

Aquis Exchange PLC

("Aquis", the "Company" or the "Group")

Exercise of Share Options

and

Total Voting Rights

Aquis Exchange PLC (AQX.L), a creator and facilitator of next-generation financial markets, announces that it has received notification from former employees exercising options under the Company's EMI Option Scheme over 18,000 ordinary shares of 10p each in the Company ("Ordinary Shares") at an exercise price of £3.47 per Ordinary Share.

Application has been made for 18,000 new Ordinary Shares to be admitted to trading on AQSE and AIM, which is expected to take place on 24 January 2024. The new Ordinary Shares will rank pari passu with the existing Ordinary Shares in issue.

Total Voting Rights

In accordance with the provisions of the Disclosure Guidance and Transparency Rules of the FCA, the Company confirms that, following this issue, its issued share capital will comprise 27,534,781 Ordinary Shares. All Ordinary Shares shall have equal voting rights and none of the Ordinary Shares are held in treasury. Accordingly, the figure of 27,534,781 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

-ends-

Enquiries:

Aquis Exchange PLC

Tel: +44 (0)20 3597 6321

Alasdair Haynes, CEO


Richard Fisher, CFO

Adele Gilbert, Head of Marketing & Investor Relations

Tel: +44 (0)20 3597 6329

Investec Bank plc (Nominated Adviser and Broker)

Tel: +44 (0)20 7597 4000

David Anderson


Bruce Garrow


Lydia Zychowska

St John Hunter

Canaccord Genuity Limited (Joint Broker)

Emma Gabriel

George Grainger

VSA Capital Limited (AQSE Corporate Adviser)

Andrew Raca

Tel: +44 (0) 20 7523 8000

Tel: +44(0)20 3005 5000

Alma Strategic Communications (Financial PR Adviser)

Tel: +44 (0)20 3405 0209

Josh Royston

Rebecca Sanders-Hewett

aquis@almastrategic.com

Kieran Breheny

Notes to editors:

About Aquis Exchange PLC

Aquis Exchange PLC ("Aquis") is a creator and facilitator of next-generation financial markets, through the provision of accessible, simple and efficient stock exchanges, trading venues and technology.

Aquis consists of four divisions:

Aquis Markets operates lit and dark order books, covering 16 European markets. For its lit books, Aquis uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade.

Aquis Technologies is the software and technology division of Aquis. It focuses on building better markets via the creation and licensing of cutting-edge, cost-effective exchange infrastructure technology and services, including matching engine and trade surveillance solutions.

Aquis Data generates revenue from the sale of data derived from Aquis Markets and Aquis Stock Exchange to non-Member market participants.

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue. The AQSE Growth Market is divided into two segments 'Access' and 'Apex'; the Access market focuses on earlier stage growth companies, while Apex is the intended market for larger, more established businesses.

Aquis is authorised and regulated by the UK Financial Conduct Authority and France's Autorité de contrôle prudentiel et de résolution and L'Autorité des marchés financiers to operate Multilateral Trading Facility businesses in the UK & Switzerland markets and in EU27 markets respectively. Aquis Exchange PLC is quoted on the Aquis Stock Exchange and on the AIM Market (AIM) of the LSE. For more information, please go to www.aquis.eu.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TVRMZGZMKFZGDZM